Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis

SIMPLE SUMMARY: In prostate cancer diagnosis and prognosis, clinicians often must take decisions on which prostate cancer-suspected patients should undergo biopsy and which prostate cancer-diagnosed patients should undergo treatment, to overcome overdiagnosis and overtreatment. Many biomarker-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Visser, Wieke C. H., de Jong, Hans, Melchers, Willem J. G., Mulders, Peter F. A., Schalken, Jack A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765473/
https://www.ncbi.nlm.nih.gov/pubmed/33339117
http://dx.doi.org/10.3390/cancers12123790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765473/
https://www.ncbi.nlm.nih.gov/pubmed/33339117
http://dx.doi.org/10.3390/cancers12123790

Ejemplares similares